Home›Stock Screener›Venus Remedies›Quarterly Results

Venus Remedies Quarterly Results

Latest Quarter Net Profit
₹48 Cr
QMar 2026
Quarterly Results

Venus Remedies quarterly results. In Mar 2026, Venus Remedies (VENUSREM) reported revenue ₹264 Cr and net profit ₹48 Cr — revenue +30.7% YoY. For annual financials, live price and key ratios, visit Venus Remedies screener.

VENUSREM Quarterly Results — Revenue, Profit & EPS Highlights

Venus Remedies latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review VENUSREM P/E comparison to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹264 Cr in Mar 2026 (+45.1% vs Jun 2026, +30.7% vs Mar 2025)
  • Net Profit of ₹48 Cr in Mar 2026 (+108.7% vs Jun 2026, +128.6% vs Mar 2025)
  • EBITDA of ₹68 Cr in Mar 2026 (+83.8% vs Jun 2026)
  • Operating Margin of 24.0% in Mar 2026 (+5.0pp vs Jun 2026)
  • Earnings Per Share of ₹35.53 in Mar 2026 (+106.8% vs Jun 2026)

Venus Remedies Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VENUSREM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 264 182 195 202 141 45.1% 30.7%
Net Profit (₹ Cr) 48 23 20 21 10 - -
EBITDA (₹ Cr) 68 37 33 36 19 - -
EPS (₹) 35.53 17.18 15.06 15.71 7.18 - -
Operating Margin (%) 24.0% 19.0% 16.0% 15.0% 11.0% - -

VENUSREM Share Price Trend — 1-Year Movement Across Quarterly Results

Venus Remedies 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Venus Remedies networth to track the company's total market size over time.

Profitability Ratios

Profit Margin 18.2%
EBITDA Margin 25.8%
Operating Margin 24.0%
ROE (Annual) 28.9%

Balance Sheet Highlights

Total Assets ₹854 Cr
Total Equity ₹664 Cr
Current Assets ₹395 Cr
Current Liabilities ₹28 Cr

Cash Flow Analysis

Operating Cash Flow ₹156 Cr
Investing Cash Flow ₹-185 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹-32 Cr

Current Market Data

Current Price ₹1796.10
Exchange NSE
Last Updated Sep 30, 2026

Revenue Trend (₹ Cr)

Mar 2025 202
Sept 2025 195
Jun 2026 182
Mar 2026 264

Net Profit Trend (₹ Cr)

Mar 2025 21
Sept 2025 20
Jun 2026 23
Mar 2026 48

Operating Margin Trend (%)

Mar 2025 15.0%
Sept 2025 16.0%
Jun 2026 19.0%
Mar 2026 24.0%

VENUSREM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Venus Remedies latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores